# Pharmaron Biologics (UK) (Pharmaron Biologics (UK) Ltd) Private limited company registered in Liverpool, classed under “Manufacture of basic pharmaceutical products”. - Company number: 04543737 - Status: Active - Type: Private limited company - Incorporated: 24 September 2002 - Registered office: 12 Estuary Banks, Speke, Liverpool, L24 8RB - Location: Liverpool - Activity: Manufacture of basic pharmaceutical products ## Latest filed profit No profit figure in its latest filed accounts. Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers. ## Questions people ask ### What does Pharmaron Biologics (UK) do? Private limited company registered in Liverpool, classed under “Manufacture of basic pharmaceutical products”. ### How much turnover does Pharmaron Biologics (UK) make? Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/pharmaron-biologics-uk-04543737 ### Is Pharmaron Biologics (UK) profitable? We haven't found a profit figure in Pharmaron Biologics (UK)'s latest filed accounts. ### How many people work at Pharmaron Biologics (UK)? Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/pharmaron-biologics-uk-04543737 ### Who runs and owns Pharmaron Biologics (UK)? Its directors are Stephen Lewinton, Stephen Christopher Lewinton, Boliang Lou. Its owners are shown to subscribers. ### Where is Pharmaron Biologics (UK) based? Its registered office is 12 Estuary Banks, Speke, Liverpool, L24 8RB, in Liverpool. ### When was Pharmaron Biologics (UK) founded? Pharmaron Biologics (UK) Ltd was incorporated on 24 September 2002. ### Is Pharmaron Biologics (UK) still trading? The register lists Pharmaron Biologics (UK) Ltd as active. ## Timeline Recent filings and changes at Companies House. - 2026-08-19: Full accounts made up to 31 December 2025 - 2025-09-22: Full accounts made up to 31 December 2024 - 2025-01-23: Resolutions (and 4 more like it since 24 January 2011) - 2025-01-22: Statement of capital following an allotment of shares on 27 December 2024 · GBP 2 (and 4 more like it since 7 February 2011) - 2024-06-03: Full accounts made up to 31 December 2023 - 2023-09-22: Full accounts made up to 31 December 2022 - 2023-02-09: Registration of charge 045437370001, created on 3 February 2023 - 2022-10-06: Full accounts made up to 31 December 2021 - 2021-10-27: Appointment of Mr Stephen Christopher Lewinton as a director on 26 October 2021 - 2021-09-07: Full accounts made up to 31 December 2020 - 2021-08-24: Cessation of Pharmaron Beijing Co Ltd as a person with significant control on 2 August 2021 - 2021-08-02: Notification of Pharmaron Beijing Co Ltd as a person with significant control on 30 April 2021 - 2021-05-11: Notification of Pharmaron Biologics (Uk) Holdings Limited as a person with significant control on 30 April 2021 - 2021-05-11: Cessation of Abbvie Inc. as a person with significant control on 30 April 2021 - 2021-05-04: Termination of appointment of Crawford David Brown as a director on 30 April 2021 - 2021-05-04: Termination of appointment of Patricia Maria Haran as a secretary on 30 April 2021 - 2021-05-04: Appointment of Mr Stephen Lewinton as a secretary on 30 April 2021 - 2021-05-04: Appointment of Dr Boliang Lou as a director on 30 April 2021 - 2021-03-09: Full accounts made up to 31 December 2019 - 2021-02-01: Statement by Directors (and 5 more like it since 30 September 2004) - 2021-02-01: Statement of capital on 1 February 2021 · GBP 1 - 2021-02-01: Solvency Statement dated 22/01/21 - 2021-01-26: Notification of Abbvie Inc. as a person with significant control on 8 May 2020 - 2021-01-26: Cessation of Allergan Plc as a person with significant control on 8 May 2020 - 2021-01-26: Notification of Allergan Plc as a person with significant control on 31 May 2018 --- Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/pharmaron-biologics-uk-04543737